Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Squamous Cell Carcinoma
Related studies linked through entity extraction aliases.
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Using MC1R Genotype to Impact Melanoma Risk Behavior
- Status
- COMPLETED
- Phase
- NA
EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Afatinib Plus Chemotherapy Against Esophageal or Lung Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology
- Status
- COMPLETED
- Phase
- N/A
T-VEC in Non-melanoma Skin Cancer
- Status
- COMPLETED
- Phase
- PHASE1
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line
- Status
- COMPLETED
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)
- Status
- COMPLETED
- Phase
- PHASE2
Strategies to Promote Skin Health
- Status
- COMPLETED
- Phase
- NA
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy
- Status
- TERMINATED
- Phase
- PHASE2
PEN-866 in Patients With Advanced Solid Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers
- Status
- COMPLETED
- Phase
- N/A
A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp
- Status
- TERMINATED
- Phase
- PHASE3